Source: Reuters

ViiV Healthcare: U.S. FDA declines to approve GSK drugs division's long acting HIV injection

GlaxoSmithKline's HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Estimated Annual Revenue

Estimated Employees

Deborah Waterhouse's photo - CEO of ViiV Healthcare

CEO

Deborah Waterhouse

CEO Approval Rating

83/100

ViiV Healthcare is a biotechnological company that develops therapies for human immunodeficiency virus.

ViiV Healthcare i...
Read more